• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China Regulatory Round-up for Medical Devices in November and December 2020

China Regulatory Round-up for Medical Devices in November and December 2020

Friday, 22 January 2021 / Published in Medical Device, NMPA Registration in China

China Regulatory Round-up for Medical Devices in November and December 2020

China Regulatory Guidelines Issued / Updated

1 GB (Guobiao) mandatory standard for transfusion sets will be implemented on June 1, 2022, whilst 2 GB mandatory standards for medical electrical equipment will be implemented on May 1, 2023.

The NMPA issued regulatory guidelines (including drafts) for 16 medical devices throughout November and December 2020:

  • Technical review guidelines for household in-vitro diagnostic devices
  • Technical review guidelines for specific protein immunoassay devices
  • Technical review guidelines for prolactin detection reagents
  • Technical review guidelines for total triiodothyronine detection reagents
  • Technical review guidelines for 25 hyrdroxyvitamin D detection reagents
  • Technical review guidelines for serum amyloid A detection reagents
  • Technical review guidelines for rheumatoid factor detection reagents
  • Technical review guidelines for nomenclature of orthopaedic surgical instruments
  • Technical review guidelines for nomenclature of blood transfusion, dialysis and cardiopulmonary bypass devices
  • Technical review guidelines for nomenclature of passive surgical instruments
  • Technical review guidelines for nomenclature of passive implantable devices
  • Technical review guidelines for nomenclature of disinfection and sterilization devices
  • Technical review guidelines for electronic upper gastrointestinal endoscope
  • Technical review guidelines for fundus camera
  • Technical review guidelines (draft) for biodegradable magnesium orthopaedic implants
  • Technical review guidelines (draft) for the use of in-vitro diagnostic reagents overseas clinical trial data

China Fast-Track Approval Updates

Amongst the applicants of the 5 medical devices pending for registration approval via the Special Review Procedure for Innovative Medical Devices, the application of the intraocular lens was submitted by Alcon Laboratories, Incorporated, an American-Swiss medical company specializing in eye care products.

The Hepatitis B virus PCR fluorescence quantitative detection kit is pending for registration approval via the Procedure for Prioritized Review, and considered as a major project in China’s national science and technology field. The applicant is a local manufacturer in Suzhou, China.

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: fast-track approval, Guobiao, Prioritized Review, Special Review Procedure, Technical Review Guidelines

What you can read next

NMPA Finally Updates IVD Reagent Classification
Technical guideline for children's cosmetics
Technical Guideline for Children’s Cosmetics in China (Draft)
Filing of Imported Non-Special Use Cosmetics with Beijing MPA

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Clinical trials of sodium hyaluronate complex solution

    Clinical trials of sodium hyaluronate complex solution – draft guidelines issued

    Clinical trials of sodium hyaluronate complex s...
  • China registration of ophthalmic optical measurement devices

    China registration of ophthalmic optical measurement devices – Technical review guidelines issued

    China registration of ophthalmic optical measur...
  • Pre-communication for Hainan medical device clinical RWD

    Pre-communication for Hainan medical device clinical RWD application – Trial measures implemented

    Pre-communication for Hainan medical device cli...
  • Registration platform for cosmetic raw materials safety information

    Registration platform for cosmetic raw materials safety information – Draft guidelines issued

    The registration platform for cosmetic raw mate...
  • Technical guidelines for reporting cosmetics formulas

    Technical guidelines for reporting cosmetics formulas – draft issued

    Technical guidelines for reporting cosmetics fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP